6 Results for "

FRβ

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "FRβ" in MCE Product Catalog:

  • Isoforms Recommended:
Cat. No.: HY-175428
CAS No.: 518063-75-7
Target:  

Antifolate

Research Areas:  

Cancer

Antifolate agent 1 is a 6-substituted pyrrolopyrimidine antifolate with a 1-carbon bridge. Antifolate agent 1 shows no activity against cells expressing FRα and FRβ, and has no GARFTase inhibitory activity. Antifolate agent 1 can be used as a negative control in the development of folate receptor-targeted antifolates .
loading...
    loading...
Cat. No.: HY-172934
FGT-4 is a folate receptor β (FR-β) targeting chimeric molecule. FGT-4 is a TLR7 agonist. FGT-4 facilitates the secretion of iNOS and proinflammatory cytokine IL-6 associated with M1 macrophages and enhances the proliferation of cytotoxic CD8 + T cells. FGT-4 has anti-tumor activity in the 4T1 breast cancer mouse model. FGT-4 can be used for the study of cancer immunity. (Pink: target protein TLR7/8 agonist 1 ligand (HY-103698); black: linker (HY-172936); blue: FR-β ligand (HY-172935)) .
loading...
    loading...
Cat. No.: HY-172935
CAS No.: 863869-78-7
Target:  

Antifolate

Research Areas:  

Cancer

FR-β ligand 1 (III), a folate receptor-targeting ligand, possesses antitumor activity, high selectivity, and stronger affinity for folate receptor .
loading...
    loading...
Cat. No.: HY-147699
CAS No.: 2028296-64-0
Target:  

Antifolate

Research Areas:  

Cancer

FRα-IN-1 (Compound 4) is a tumor-targeting agent. FRα-IN-1 shows selective anticancer activity towards folate receptors (FRα and FRβ) expression cells .
loading...
    loading...
Cat. No.: HY-172936
Target:  

Drug Intermediate

Research Areas:  

Cancer

L-Serine-S2-PEG-Formic acid is a linker for FGT-4 (HY-172934). FGT-4, a TLR7 agonist, is a folate receptor β (FR-β) targeting chimeric molecule .
loading...
    loading...
Cat. No.: HY-157217
Target:  

Antifolate

Research Areas:  

Cancer

Antitumor agent-99 (compound 7) is an anticancer agent targeting FRα/β and PCFT. Antitumor agent-99 inhibits R2/PCFT4 (PCFT), RT16(FRα), and D4(FRβ) cells with IC50s of 51.46 nM, 2.53 nM, and 2.98 nM, respectively .
loading...
    loading...